Skip to Content

500 Results Found

  • Review
  • Open Access
51 Citations
10,985 Views
23 Pages

Alpha-Synuclein and Cognitive Decline in Parkinson Disease

  • Tian-Sin Fan,
  • Sam Chi-Hao Liu and
  • Ruey-Meei Wu

16 November 2021

Parkinson disease (PD) is the second most common neurodegenerative disorder in elderly people. It is characterized by the aggregation of misfolded alpha-synuclein throughout the nervous system. Aside from cardinal motor symptoms, cognitive impairment...

(This article belongs to the Special Issue Alpha-Synuclein and Non-Motor Symptoms of Parkinson’s Disease)
  • Article
  • Open Access
12 Citations
5,010 Views
13 Pages

Inhibition of Ubiquitin-Specific Protease-13 Improves Behavioral Performance in Alpha-Synuclein Expressing Mice

  • Xiaoguang Liu,
  • Kaluvu Balaraman,
  • Ciarán C. Lynch,
  • Michaeline Hebron and ,
  • Priya Ketankumar Shah,
  • Shicheng Hu,
  • Max Stevenson,
  • Christian Wolf and
  • Charbel Moussa
  • + 4 authors+ 0 author

Ubiquitin-Specific Protease-13 (USP13) promotes protein de-ubiquitination. USP13 levels are upregulated in post-mortem Parkinson’s disease, whereas USP13 knockdown via shRNA reduces alpha-synuclein levels in animal models. We studied the role o...

(This article belongs to the Special Issue Synucleins in Neurodegeneration)
  • Article
  • Open Access
13 Citations
3,357 Views
12 Pages

Hydroxycinnamic Acid Derivatives from Coffee Extracts Prevent Amyloid Transformation of Alpha-Synuclein

  • Maria Medvedeva,
  • Natalia Kitsilovskaya,
  • Yulia Stroylova,
  • Irina Sevostyanova and ,
  • Ali Akbar Saboury and
  • Vladimir Muronetz
  • + 1 author+ 0 author

12 September 2022

Earlier we showed that derivatives of hydroxycinnamic acids prevent amyloid transformation of alpha-synuclein and prion protein. The aim of this work was to determine the content of 3-hydroxycinnamic acid derivatives in coffee extracts and to evaluat...

(This article belongs to the Special Issue Molecular Research of Neurodegenerative and Psychiatric Diseases)
  • Article
  • Open Access
10 Citations
3,637 Views
12 Pages

Targeted Extracellular Vesicle Gene Therapy for Modulating Alpha-Synuclein Expression in Gut and Spinal Cord

  • Maria Izco,
  • Martin Schleef,
  • Marco Schmeer,
  • Estefania Carlos and ,
  • Guglielmo Verona and
  • Lydia Alvarez-Erviti
  • + 1 author+ 0 author

The development of effective disease-modifying therapies to halt Parkinson’s disease (PD) progression is required. In a subtype of PD patients, alpha-synuclein pathology may start in the enteric nervous system (ENS) or autonomic peripheral nerv...

(This article belongs to the Special Issue Novel Therapeutic Approaches for Neurodegenerative Diseases Treatment)
  • Review
  • Open Access
14 Citations
8,712 Views
27 Pages

Cellular Models of Alpha-Synuclein Aggregation: What Have We Learned and Implications for Future Study

  • Katrina Albert,
  • Sara Kälvälä,
  • Vili Hakosalo,
  • Valtteri Syvänen and ,
  • Patryk Krupa,
  • Jonna Niskanen,
  • Sanni Peltonen,
  • Tuuli-Maria Sonninen and
  • Šárka Lehtonen
  • + 4 authors+ 0 author

Alpha-synuclein’s role in diseases termed “synucleinopathies”, including Parkinson’s disease, has been well-documented. However, after over 25 years of research, we still do not fully understand the alpha-synuclein protein and...

(This article belongs to the Special Issue Recent Advances in Understanding of the Role of Synuclein Family Members in Health and Disease)
  • Article
  • Open Access
10 Citations
4,297 Views
25 Pages

The Role of Membrane Affinity and Binding Modes in Alpha-Synuclein Regulation of Vesicle Release and Trafficking

  • Tapojyoti Das,
  • Meraj Ramezani,
  • David Snead,
  • Cristian Follmer and ,
  • Peter Chung,
  • Ka Yee Lee,
  • David A. Holowka,
  • Barbara A. Baird and
  • David Eliezer
  • + 4 authors+ 0 author

5 December 2022

Alpha-synuclein is a presynaptic protein linked to Parkinson’s disease with a poorly characterized physiological role in regulating the synaptic vesicle cycle. Using RBL-2H3 cells as a model system, we earlier reported that wild-type alpha-synu...

(This article belongs to the Special Issue Physics of Protein Folding, Misfolding, and Intrinsic Disorder: A Themed Issue in Honour of Professor Vladimir Uversky on the Occasion of His 60th Birthday)
  • Article
  • Open Access
13 Citations
5,320 Views
16 Pages

Alpha-Synuclein FRET Biosensors Reveal Early Alpha-Synuclein Aggregation in the Endoplasmic Reticulum

  • Fabiana Miraglia,
  • Verdiana Valvano,
  • Lucia Rota,
  • Cristina Di Primio and ,
  • Valentina Quercioli,
  • Laura Betti,
  • Gino Giannaccini,
  • Antonino Cattaneo and
  • Emanuela Colla
  • + 4 authors+ 0 author

11 August 2020

Endoplasmic reticulum (ER) dysfunction is important for alpha-synuclein (αS) acquired toxicity. When targeted to the ER in SH-SY5Y cells, transient or stable expression of αS resulted in the formation of compact αS-positive structur...

(This article belongs to the Collection Function, Regulation, and Dysfunction of Intrinsically Disordered Proteins)
  • Article
  • Open Access
6 Citations
3,366 Views
11 Pages

Cerebrospinal Fluid Alpha-Synuclein Improves the Differentiation between Dementia with Lewy Bodies and Alzheimer’s Disease in Clinical Practice

  • Matthieu Lilamand,
  • Josué Clery,
  • Agathe Vrillon,
  • François Mouton-Liger and ,
  • Emmanuel Cognat,
  • Sinead Gaubert,
  • Claire Hourregue,
  • Matthieu Martinet,
  • Julien Dumurgier and
  • Claire Paquet
  • + 7 authors+ 2 authors

4 November 2022

Background: Alpha-synuclein, abnormally aggregated in Dementia with Lewy Bodies (DLB), could represent a potential biomarker to improve the differentiation between DLB and Alzheimer’s disease (AD). Our main objective was to compare Cerebrospina...

(This article belongs to the Special Issue Molecular Biomarkers in Neurological Diseases)
  • Article
  • Open Access
60 Citations
4,899 Views
13 Pages

Polymorphism of Alpha-Synuclein Amyloid Fibrils Depends on Ionic Strength and Protein Concentration

  • Mantas Ziaunys,
  • Andrius Sakalauskas,
  • Kamile Mikalauskaite and
  • Vytautas Smirnovas

17 November 2021

Protein aggregate formation is linked with multiple amyloidoses, including Alzheimer‘s and Parkinson‘s diseases. Currently, the understanding of such fibrillar structure formation and propagation is still not sufficient, the outcome of which is a lac...

(This article belongs to the Special Issue The Role of Environment in Amyloid Aggregation 2.0)
  • Article
  • Open Access
17 Citations
5,040 Views
11 Pages

Alpha-Synuclein Amyloid Aggregation Is Inhibited by Sulfated Aromatic Polymers and Pyridinium Polycation

  • Pavel Semenyuk,
  • Lidia Kurochkina,
  • Kseniya Barinova and
  • Vladimir Muronetz

28 February 2020

The effect of a range of synthetic charged polymers on alpha-synuclein aggregation and amyloid formation was tested. Sulfated aromatic polymers, poly(styrene sulfonate) and poly(anethole sulfonate), have been found to suppress the fibril formation. I...

(This article belongs to the Special Issue Biopolymers for Medical Applications)
  • Review
  • Open Access
1,271 Views
13 Pages

5 March 2026

Background: Frontotemporal dementia (FTD) is traditionally classified based on the accumulation of either tau or TDP-43 proteins; however, the presence of alpha-synuclein (α-Syn) in these patients is increasingly recognized as a critical factor...

(This article belongs to the Special Issue Role of Alpha-Synuclein in Neurodegenerative Diseases)
  • Article
  • Open Access
3 Citations
2,286 Views
19 Pages

A Structural Proteomics Exploration of Synphilin-1 and Alpha-Synuclein Interaction in Pathogenesis of Parkinson’s Disease

  • Asmita Tripathi,
  • Rajkrishna Mondal,
  • Malay Mandal,
  • Tapobrata Lahiri and
  • Manoj Kumar Pal

12 December 2024

Pathological significance of interaction of Synphilin-1 with mutated alpha-synuclein is well known to have serious consequences in causing the formation of inclusion bodies that are linked to Parkinson’s disease (PD). Information extracted so f...

(This article belongs to the Section Bioinformatics and Systems Biology)
  • Article
  • Open Access
14 Citations
4,341 Views
20 Pages

Alpha-Synuclein and Its Role in Melanocytes

  • Nicole Rachinger,
  • Nora Mittag,
  • Ines Böhme-Schäfer,
  • Wei Xiang and ,
  • Silke Kuphal and
  • Anja K. Bosserhoff
  • + 1 author+ 0 author

30 June 2022

Pigmentation is an important process in skin physiology and skin diseases and presumably also plays a role in Parkinson’s disease (PD). In PD, alpha-Synuclein (aSyn) has been shown to be involved in the pigmentation of neurons. The presynaptic...

  • Review
  • Open Access
23 Citations
5,277 Views
13 Pages

Revisiting Alpha-Synuclein Pathways to Inflammation

  • Patrícia Lyra,
  • Vanessa Machado,
  • Silvia Rota,
  • Kallol Ray Chaudhuri and ,
  • João Botelho and
  • José João Mendes
  • + 1 author+ 0 author

Alpha-synuclein (α-Syn) is a short presynaptic protein with an active role on synaptic vesicle traffic and the neurotransmitter release and reuptake cycle. The α-Syn pathology intertwines with the formation of Lewy Bodies (multiprotein in...

(This article belongs to the Special Issue Neurobiology of Protein Synuclein)
  • Article
  • Open Access
6 Citations
3,740 Views
17 Pages

Does the SARS-CoV-2 Spike Receptor-Binding Domain Hamper the Amyloid Transformation of Alpha-Synuclein after All?

  • Yulia Stroylova,
  • Anastasiia Konstantinova,
  • Victor Stroylov,
  • Ivan Katrukha and ,
  • Fedor Rozov and
  • Vladimir Muronetz
  • + 1 author+ 0 author

Interactions of key amyloidogenic proteins with SARS-CoV-2 proteins may be one of the causes of expanding and delayed post-COVID-19 neurodegenerative processes. Furthermore, such abnormal effects can be caused by proteins and their fragments circulat...

(This article belongs to the Special Issue Recent Advances in Understanding of the Role of Synuclein Family Members in Health and Disease)
  • Article
  • Open Access
11 Citations
3,792 Views
17 Pages

Altered Sphingolipid Hydrolase Activities and Alpha-Synuclein Level in Late-Onset Schizophrenia

  • Tatiana Usenko,
  • Anastasia Bezrukova,
  • Katerina Basharova,
  • Galina Baydakova and ,
  • Elena Shagimardanova,
  • Nataliya Blatt,
  • Albert Rizvanov,
  • Oleg Limankin,
  • Maxim Novitskiy and
  • Sofya Pchelina
  • + 21 authors+ 16 authors

31 December 2023

Recent data described that patients with lysosomal storage disorders (LSDs) may have clinical schizophrenia (SCZ) features. Disruption of lipid metabolism in SCZ pathogenesis was found. Clinical features of schizophrenia (SCZ) have been demonstrated...

(This article belongs to the Section Integrative Metabolomics)
  • Concept Paper
  • Open Access
14 Citations
8,360 Views
6 Pages

Clearing Extracellular Alpha-Synuclein from Cerebrospinal Fluid: A New Therapeutic Strategy in Parkinson’s Disease

  • Manuel Menéndez-González,
  • Huber S. Padilla-Zambrano,
  • Cristina Tomás-Zapico and
  • Benjamin Fernández García

This concept article aims to show the rationale of targeting extracellular α-Synuclein (α-Syn) from cerebrospinal fluid (CSF) as a new strategy to remove this protein from the brain in Parkinson’s disease (PD). Misfolding and intracellular aggregatio...

(This article belongs to the Section Developmental Neuroscience)
  • Article
  • Open Access
11 Citations
7,976 Views
10 Pages

Patients with Parkinson’s disease (PD) have increased susceptibility to bisphenol A (BPA) exposure since they have an impaired biotransformation capacity to metabolize BPA. PD subjects have reduced levels of conjugated BPA compared to controls....

(This article belongs to the Section Toxicology)
  • Article
  • Open Access
8 Citations
3,999 Views
13 Pages

30 September 2022

Alpha-synuclein is a key protein involved in the development and progression of Parkinson’s disease and other synucleinopathies. The intrinsically disordered nature of alpha-synuclein hinders the computational screening of new drug candidates f...

(This article belongs to the Special Issue Protein Folding)
  • Review
  • Open Access
100 Citations
16,410 Views
37 Pages

The Interplay between Alpha-Synuclein Clearance and Spreading

  • Tomás Lopes da Fonseca,
  • Anna Villar-Piqué and
  • Tiago Fleming Outeiro

14 April 2015

Parkinson’s Disease (PD) is a complex neurodegenerative disorder classically characterized by movement impairment. Pathologically, the most striking features of PD are the loss of dopaminergic neurons and the presence of intraneuronal protein inclus...

(This article belongs to the Special Issue Exploring the Mechanisms by which α-Synuclein Kills Cells in Parkinson Disease)
  • Article
  • Open Access
820 Views
15 Pages

Features of Cross-Seeding of Wild-Type Alpha-Synuclein and Its Mutant Form A53T Potentially Useful for the Development of Test Systems

  • Kseniya Barinova,
  • Sofiya Kudryavtseva,
  • Lidia Kurochkina,
  • Sergei Golyshev and ,
  • Nataliya Kolotyeva,
  • Sergei Illarioshkin,
  • Michail Piradov and
  • Vladimir Muronetz
  • + 3 authors+ 0 author

15 April 2026

Since the features of cross-seeding of alpha-synuclein forms may affect the sensitivity and specificity of the test systems, we developed a modified approach to obtain alpha-synuclein amyloid seeds with particle sizes from 20 to 50 nm prepared from e...

(This article belongs to the Section Medical Research)
  • Communication
  • Open Access
33 Citations
4,983 Views
7 Pages

Alpha-Synuclein RNA Expression is Increased in Major Depression

  • Andrea Rotter,
  • Bernd Lenz,
  • Ruben Pitsch,
  • Tanja Richter-Schmidinger and ,
  • Johannes Kornhuber and
  • Cosima Rhein
  • + 1 author+ 0 author

Alpha-synuclein (SNCA) is a small membrane protein that plays an important role in neuro-psychiatric diseases. It is best known for its abnormal subcellular aggregation in Lewy bodies that serves as a hallmark of Parkinson’s disease (PD). Due t...

(This article belongs to the Special Issue Molecular Psychiatry)
  • Article
  • Open Access
1 Citations
1,858 Views
13 Pages

This work aimed to study the effect of repeated exposure to low doses of ozone on alpha-synuclein and the inflammatory response in the substantia nigra, jejunum, and colon. Seventy-two male Wistar rats were divided into six groups. Each group receive...

(This article belongs to the Section Molecular Toxicology)
  • Review
  • Open Access
23 Citations
10,260 Views
21 Pages

17 November 2020

The primary pathogenesis associated with Parkinson’s disease (PD) occurs in peripheral tissues several years before the onset of typical motor symptoms. Early and reliable diagnosis of PD could provide new treatment options for PD patients and...

(This article belongs to the Special Issue Peripheral Biomarkers in Neurodegenerative Diseases 2.0)
  • Feature Paper
  • Review
  • Open Access
122 Citations
14,221 Views
19 Pages

12 February 2021

The accumulation of misfolded alpha-synuclein (aSyn) throughout the brain, as Lewy pathology, is a phenomenon central to Parkinson’s disease (PD) pathogenesis. The stereotypical distribution and evolution of the pathology during disease is often attr...

(This article belongs to the Special Issue Hallmarks of Parkinson’s Disease)
  • Review
  • Open Access
31 Citations
6,506 Views
34 Pages

Alpha-Synuclein in Peripheral Tissues as a Possible Marker for Neurological Diseases and Other Medical Conditions

  • Félix Javier Jiménez-Jiménez,
  • Hortensia Alonso-Navarro,
  • Elena García-Martín,
  • Diego Santos-García and ,
  • Iván Martínez-Valbuena and
  • José A. G. Agúndez
  • + 1 author+ 0 author

18 August 2023

The possible usefulness of alpha-synuclein (aSyn) determinations in peripheral tissues (blood cells, salivary gland biopsies, olfactory mucosa, digestive tract, skin) and in biological fluids, except for cerebrospinal fluid (serum, plasma, saliva, fe...

(This article belongs to the Section Molecular Medicine)
  • Review
  • Open Access
75 Citations
8,656 Views
19 Pages

Alpha-Synuclein and Mitochondrial Dysfunction in Parkinson’s Disease: The Emerging Role of VDAC

  • Pierpaolo Risiglione,
  • Federica Zinghirino,
  • Maria Carmela Di Rosa,
  • Andrea Magrì and
  • Angela Messina

Alpha-Synuclein (αSyn) is a protein whose function is still debated, as well as its role in modulation of mitochondrial function in both physiological and pathological conditions. Mitochondrial porins or Voltage-Dependent Anion Channel (VDAC) protein...

(This article belongs to the Special Issue α-Synuclein Amyloids & Parkinson’s Disease: On Growth, Spread, and Neurodegeneration)
  • Review
  • Open Access
24 Citations
8,600 Views
24 Pages

Passive Immunization in Alpha-Synuclein Preclinical Animal Models

  • Jonas Folke,
  • Nelson Ferreira,
  • Tomasz Brudek,
  • Per Borghammer and
  • Nathalie Van Den Berge

20 January 2022

Alpha-synucleinopathies include Parkinson’s disease, dementia with Lewy bodies, pure autonomic failure and multiple system atrophy. These are all progressive neurodegenerative diseases that are characterized by pathological misfolding and accum...

(This article belongs to the Section Molecular Biology)
  • Article
  • Open Access
905 Views
17 Pages

Introduction: Pathogenic mutations in leucine-rich repeat protein kinase-2 (LRRK2), particularly G2019S, constitute the most common cause of autosomal dominant PD. Methods: Mouse models encoding human mutant alpha-synuclein (SNCA A53T) and LRRK2 G201...

(This article belongs to the Special Issue Cell Metabolism in Brain Physiology and Pathology: From Molecular Mechanisms to Therapeutic Targets)
  • Review
  • Open Access
49 Citations
10,964 Views
21 Pages

28 November 2024

Parkinson’s disease (PD) is a neurodegenerative disorder characterized by both motor symptoms and non-motor features. A hallmark of PD is the misfolding and accumulation of alpha-synuclein (α-syn), which triggers neuroinflammation and dri...

(This article belongs to the Section Clinical Neurology)
  • Article
  • Open Access
14 Citations
5,939 Views
15 Pages

Expression Levels of an Alpha-Synuclein Transcript in Blood May Distinguish between Early Dementia with Lewy Bodies and Parkinson’s Disease

  • Laura Marsal-García,
  • Aintzane Urbizu,
  • Laura Arnaldo,
  • Jaume Campdelacreu and ,
  • Dolores Vilas,
  • Lourdes Ispierto,
  • Jordi Gascón-Bayarri,
  • Ramón Reñé,
  • Ramiro Álvarez and
  • Katrin Beyer
  • + 5 authors+ 0 author

Lewy body diseases (LBD) including dementia with Lewy bodies (DLB) and Parkinson disease (PD) are characterized by alpha-synuclein pathology. DLB is difficult to diagnose and peripheral biomarkers are urgently needed. Therefore, we analyzed the expre...

(This article belongs to the Special Issue Translating Genetic Discoveries in Neurodegenerative Diseases Research)
  • Hypothesis
  • Open Access
19 Citations
7,071 Views
9 Pages

Production of Recombinant Alpha-Synuclein: Still No Standardized Protocol in Sight

  • Mohammed Al-Azzani,
  • Annekatrin König and
  • Tiago Fleming Outeiro

18 February 2022

Synucleinopathies are a group of neurodegenerative diseases, characterized by the abnormal accumulation of the protein alpha-synuclein (aSyn). aSyn is an intrinsically disordered protein that can adopt different aggregation states, some of which may...

(This article belongs to the Special Issue α-Synuclein Amyloids & Parkinson’s Disease: On Growth, Spread, and Neurodegeneration)
  • Article
  • Open Access
50 Citations
8,288 Views
17 Pages

Blood Contamination in CSF and Its Impact on Quantitative Analysis of Alpha-Synuclein

  • Katalin Barkovits,
  • Niels Kruse,
  • Andreas Linden,
  • Lars Tönges and ,
  • Kathy Pfeiffer,
  • Brit Mollenhauer and
  • Katrin Marcus
  • + 2 authors+ 0 author

5 February 2020

Analysis of cerebrospinal fluid (CSF) is important for diagnosis of neurological diseases. Especially for neurodegenerative diseases, abnormal protein abundance in CSF is an important biomarker. However, the quality of CSF is a key factor for the ana...

(This article belongs to the Special Issue The Molecular and Cellular Basis for Parkinson's Disease 2019)
  • Proceeding Paper
  • Open Access
2,542 Views
2 Pages

Inflammatory Bowel Disease, Alpha-Synuclein Aggregates and Parkinson’s Disease: The InflamaSPark Protocol

  • Miguel Grunho,
  • Catarina Godinho,
  • Marta Patita,
  • Irina Mocanu and ,
  • Ana Isabel Vieira,
  • António Alves de Matos,
  • Ricardo Carregosa,
  • Frederico Marx,
  • Morgane Tomé and
  • Jorge Fonseca
  • + 8 authors+ 3 authors

The hallmark of Parkinson’s disease (PD) is the accumulation of alpha-synuclein (AS) aggregates. Prior to the central nervous system involvement, PD establishes itself in the gut as a result of the complex interplay between microbiota, the host’s imm...

(This article belongs to the Proceedings of The 5th International Congress of CiiEM (IC CiiEM))
  • Review
  • Open Access
45 Citations
9,939 Views
32 Pages

In neuronal cells, tau is a microtubule-associated protein placed in axons and alpha synuclein is enriched at presynaptic terminals. They display a propensity to form pathologic aggregates, which are considered the underlying cause of Alzheimer&rsquo...

(This article belongs to the Special Issue Intrinsically Disordered Proteins (IDPs): From Physical Chemistry to Pathogenic Mechanisms)
  • Review
  • Open Access
6 Citations
4,999 Views
19 Pages

Alpha-synuclein (αS) is a small, presynaptic neuronal protein encoded by the SNCA gene. Point mutations and gene multiplication of SNCA cause rare familial forms of Parkinson’s disease (PD). Misfolded αS is cytotoxic and is a compon...

(This article belongs to the Special Issue The Structure and Function of Synuclein)
  • Article
  • Open Access
8 Citations
3,206 Views
12 Pages

Alpha-Synuclein Interaction with UBL3 Is Upregulated by Microsomal Glutathione S-Transferase 3, Leading to Increased Extracellular Transport of the Alpha-Synuclein under Oxidative Stress

  • Jing Yan,
  • Tomoaki Kahyo,
  • Hengsen Zhang,
  • Yashuang Ping and ,
  • Chi Zhang,
  • Shuyun Jiang,
  • Qianqing Ji,
  • Rafia Ferdous,
  • Md. Shoriful Islam and
  • Mitsutoshi Setou
  • + 10 authors+ 5 authors

Aberrant aggregation of misfolded alpha-synuclein (α-syn), a major pathological hallmark of related neurodegenerative diseases such as Parkinson’s disease (PD), can translocate between cells. Ubiquitin-like 3 (UBL3) is a membrane-anchored...

(This article belongs to the Special Issue Synucleins in Neurodegeneration)
  • Review
  • Open Access
18 Citations
4,327 Views
25 Pages

Beyond Strains: Molecular Diversity in Alpha-Synuclein at the Center of Disease Heterogeneity

  • Marcelina J. Wojewska,
  • Maria Otero-Jimenez,
  • Jose Guijarro-Nuez and
  • Javier Alegre-Abarrategui

25 August 2023

Alpha-synucleinopathies (α-synucleinopathies) such as Parkinson’s disease (PD), Parkinson’s disease dementia (PDD), dementia with Lewy bodies (DLB), and multiple system atrophy (MSA) are all characterized by aggregates of alpha-synu...

(This article belongs to the Section Molecular Neurobiology)
  • Review
  • Open Access
43 Citations
7,664 Views
15 Pages

30 April 2022

Alpha-synuclein (α-syn) is a small protein composed of 140 amino acids and belongs to the group of intrinsically disordered proteins. It is a soluble protein that is highly expressed in neurons and expressed at low levels in glial cells. The mo...

(This article belongs to the Special Issue Recent Advances in α-Synuclein Neurobiology in Health and Disease)
  • Review
  • Open Access
7 Citations
3,685 Views
30 Pages

3 March 2026

Alpha-synuclein (αSyn) is one of the most abundant proteins in the nervous system and is currently associated with devastating synucleinopathies, yet its biology extends far beyond this. In this review, we suggest that αSyn-driven disease...

(This article belongs to the Special Issue Role of Alpha-Synuclein in Neurodegenerative Diseases)
  • Article
  • Open Access
7 Citations
2,553 Views
14 Pages

Early Effects of Alpha-Synuclein Depletion by Pan-Neuronal Inactivation of Encoding Gene on Electroencephalogram Coherence between Different Brain Regions in Mice

  • Vasily Vorobyov,
  • Alexander Deev,
  • Olga Morozova,
  • Zoya Oganesyan and ,
  • Anastasia M. Krayushkina,
  • Tamara A. Ivanova and
  • Kirill Chaprov
  • + 2 authors+ 0 author

12 December 2023

Inactivation of the Snca gene in young mice by chronic injections of tamoxifen (TAM), a selective estrogen receptor modifier, has been shown to decrease the level of alpha-synuclein, a key peptide in the pathogenesis of Parkinson’s disease. In young...

(This article belongs to the Special Issue Recent Advances in Understanding of the Role of Synuclein Family Members in Health and Disease Volume II)
  • Communication
  • Open Access
693 Views
11 Pages

Background/objectives: Alpha-synuclein (aSyn) is best known for its role in Parkinson’s disease. Increasing evidence suggests a bidirectional relationship between diabetes mellitus and synuclein pathology. Carboxymethyllysine (CML), an advanced...

(This article belongs to the Section Neurobiology and Clinical Neuroscience)
  • Article
  • Open Access
14 Citations
3,432 Views
21 Pages

Modulatory Role of TPPP3 in Microtubule Organization and Its Impact on Alpha-Synuclein Pathology

  • Judit Oláh,
  • Attila Lehotzky,
  • Tibor Szénási,
  • Tímea Berki and
  • Judit Ovádi

27 September 2022

Parkinson’s disease is characterized by locomotion deficits, dopaminergic neuronal loss and alpha-synuclein (SYN) aggregates; the Tubulin Polymerization Promoting Protein (TPPP/p25 or TPPP1) is also implicated in these processes. The moonlighti...

  • Review
  • Open Access
107 Citations
14,399 Views
45 Pages

Alpha-Synuclein PET Tracer Development—An Overview about Current Efforts

  • Špela Korat,
  • Natasha Shalina Rajani Bidesi,
  • Federica Bonanno,
  • Adriana Di Nanni and ,
  • Anh Nguyên Nhât Hoàng,
  • Kristina Herfert,
  • Andreas Maurer,
  • Umberto Maria Battisti,
  • Gregory David Bowden and
  • Matthias Manfred Herth
  • + 8 authors+ 3 authors

26 August 2021

Neurodegenerative diseases such as Parkinson’s disease (PD) are manifested by inclusion bodies of alpha-synuclein (α-syn) also called α-synucleinopathies. Detection of these inclusions is thus far only possible by histological examination of postmort...

(This article belongs to the Section Radiopharmaceutical Sciences)
  • Review
  • Open Access
57 Citations
10,194 Views
32 Pages

The Role of Alpha-Synuclein and Other Parkinson’s Genes in Neurodevelopmental and Neurodegenerative Disorders

  • C. Alejandra Morato Torres,
  • Zinah Wassouf,
  • Faria Zafar,
  • Danuta Sastre and ,
  • Tiago Fleming Outeiro and
  • Birgitt Schüle
  • + 1 author+ 0 author

10 August 2020

Neurodevelopmental and late-onset neurodegenerative disorders present as separate entities that are clinically and neuropathologically quite distinct. However, recent evidence has highlighted surprising commonalities and converging features at the cl...

(This article belongs to the Special Issue Translating Genetic Discoveries in Neurodegenerative Diseases Research)
  • Article
  • Open Access
13 Citations
5,608 Views
18 Pages

Chronic Exposure to Paraquat Induces Alpha-Synuclein Pathogenic Modifications in Drosophila

  • Jean-Noël Arsac,
  • Marianne Sedru,
  • Mireille Dartiguelongue,
  • Johann Vulin and ,
  • Nathalie Davoust,
  • Thierry Baron and
  • Bertrand Mollereau
  • + 2 authors+ 0 author

27 October 2021

Parkinson’s disease (PD) is characterized by the progressive accumulation of neuronal intracellular aggregates largely composed of alpha-Synuclein (αSyn) protein. The process of αSyn aggregation is induced during aging and enhanced by environmental s...

(This article belongs to the Special Issue Drosophila Models for Neurodegenerative Diseases: Achievements and Prospects)
  • Review
  • Open Access
25 Citations
7,138 Views
26 Pages

Recent Insights into the Interplay of Alpha-Synuclein and Sphingolipid Signaling in Parkinson’s Disease

  • Joanna A. Motyl,
  • Joanna B. Strosznajder,
  • Agnieszka Wencel and
  • Robert P. Strosznajder

Molecular studies have provided increasing evidence that Parkinson’s disease (PD) is a protein conformational disease, where the spread of alpha-synuclein (ASN) pathology along the neuraxis correlates with clinical disease outcome. Pathogenic forms o...

(This article belongs to the Special Issue Cell Signaling in Neurodegeneration 2.0)
  • Review
  • Open Access
57 Citations
13,216 Views
15 Pages

Parkinson’s Disease (PD) is the second-most common neurodegenerative disease in the world, yet the fundamental and underlying causes of the disease are largely unknown, and treatments remain sparse and impotent. Several biological systems have...

(This article belongs to the Special Issue Frontiers in Parkinson’s Disease (PD))
  • Review
  • Open Access
51 Citations
12,080 Views
14 Pages

9 August 2021

Parkinson’s disease (PD) is a common and progressive neurodegenerative disease, caused by the loss of dopaminergic neurons in the substantia nigra pars compacta in the midbrain, which is clinically characterized by a constellation of motor and non-mo...

(This article belongs to the Special Issue Alpha-Synuclein and Non-Motor Symptoms of Parkinson’s Disease)
  • Feature Paper
  • Review
  • Open Access
40 Citations
8,094 Views
20 Pages

Novel Immunotherapeutic Approaches to Target Alpha-Synuclein and Related Neuroinflammation in Parkinson’s Disease

  • Maria Angela Samis Zella,
  • Judith Metzdorf,
  • Friederike Ostendorf,
  • Fabian Maass and ,
  • Siegfried Muhlack,
  • Ralf Gold,
  • Aiden Haghikia and
  • Lars Tönges
  • + 3 authors+ 0 author

31 January 2019

The etiology of Parkinson’s disease (PD) is significantly influenced by disease-causing changes in the protein alpha-Synuclein (aSyn). It can trigger and promote intracellular stress and thereby impair the function of dopaminergic neurons. Howe...

(This article belongs to the Special Issue The Molecular and Cellular Basis for Parkinson's Disease)

of 10